Dr. Wei Du

Biography

Wei Du is a Professor at the University of Chicago in the Ben May Department of Cancer Research. He has a distinguished academic background with a B.S. in Biochemistry from Fudan University, followed by a Ph.D. in Biochemistry and Molecular Biology from Harvard University. He completed his postdoctoral training in Molecular Oncology at Harvard Medical School and Massachusetts General Hospital Cancer Center. His research focuses on tumor suppressor mechanisms, particularly the retinoblastoma (Rb) protein, and their implications for targeted cancer therapies. His lab investigates the novel approaches to target loss of tumor suppressors in cancers, leveraging synthetic lethality and molecular mechanisms to understand cell proliferation and differentiation. Dr. Du has been recognized with several prestigious awards such as the Sydney Kimmel Scholar and the Leukemia & Lymphoma Society Scholar honors. He actively participates in funding activities, having received multiple NIH grants for research on EGFR signaling and Rb mutant cancers, among others. His contributions to cancer research are documented through various publications, showcasing his expertise in utilizing model systems like Drosophila to elucidate mechanisms controlling cell fate in development and cancer.

Research Interests

Experience

Awards